The BAA outlines research areas of interest that will help fulfill the FDA requirements to utilize capabilities for state of the art advancement and achieve improvements in technology, materials, processes, methods, devices, or techniques in specific topics. The BAA runs for a period of 1 year and solicits proposals that focus on the following areas of interest: toxicology, personalized medicine, improve manufacturing and quality,emerging technologies, harnessing data, food safety, medical countermeasures. ON TRACK ON TRACK A. Publish BAA 5/23/2012 Completed 5/23/2012 B. Train First Review Committee 6/25/2012 Completed 6/25/2012 C. Convene First Review Committee 7/12/2012 Completed 7/12/2012 D. Award Contracts 3/31/2011 Completed 12/5/2010 E. Begin additional training (training is ongoing) 11/30/2012 <i>(5/31/2013)</i> On Track F. Amend and Renew BAA 5/31/2013 Not Yet Started G. Hold BAA proposal conference 6/30/2013 Completed 3/25/2013 H. Complete 4th quarter white paper reviews 7/31/2013 Not Yet Started The dates in italics under the milestone due dates are modified milestone due dates which had to be updated due to real-time delays. The milestone status reflects the revised dates. http://www.fda.gov/AboutFDA/Transparency/track/ucm206688.htm FDA-TRACK OC Office of the Chief Scientist Dashboard ਍††਍਍਍਍਍਍਍